Results 241 to 250 of about 482,975 (382)

Incidence and Predictors of Hypoattenuated Thickening and Device‐Related Thrombus at Three Months Postprocedural CT Assessment Following Left Atrial Appendage Occlusion With Amplatzer Devices—A Single‐Center Cohort

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Left atrial appendage occlusion (LAAO) has become a valuable alternative to long‐term anticoagulation for stroke prevention in patients with non‐valvular atrial fibrillation (AF), especially in those at high bleeding risk. Hypoattenuated thickening (HAT) and device‐related thrombus (DRT) remain notable postprocedural concerns ...
Pierre Guilleminot, Carole Richard, Antoine Roger, Marlène Daller, Gabriel Laurent, Catherine Vergely, Charles Guenancia, Thibaut Pommier   +7 more
wiley   +1 more source

Oral anticoagulation for adults with atrial fibrillation or venous thromboembolism. [PDF]

Aust Prescr
Chin PK, Doogue MP.
europepmc   +1 more source

Harnessing Algal Biorefineries for Waste to Wealth Paradigm: A Pathway Toward Circular and Sustainable Bioeconomy

CleanMat, EarlyView.
This review highlights the use of wastewater from various sources including industrial, municipal, and agricultural effluents for microalgal cultivation. It emphasizes on the integrated approach of wastewater treatment and microalgal biomass production for high value‐added bioproducts such as biofuels, animal feed, biofertilizers, bioplastics while ...
Prachi Bhatnagar, Sonia Choudhary, Anwesha Dey, Krishna Mohan Poluri   +3 more
wiley   +1 more source

Perioperative Outcomes With Direct Oral Anticoagulants in Orthopaedic Trauma Surgery: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Kyaw O, Khin C.
europepmc   +1 more source

Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160‐mg Tablet: Results From 2 Phase 1 Studies in Healthy Volunteers

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Zanubrutinib is a next‐generation Bruton tyrosine kinase inhibitor approved for treating B‐cell malignancies. Two phase 1 studies evaluated a new 160‐mg zanubrutinib tablet versus 80‐mg capsules. In study BGB‐3111‐115 (n = 43), a randomized 3‐period crossover trial, relative bioavailability and food effects were assessed.
Bilal Tariq, Chester Lin, Vaibhav Mundra, Yang Gao, Dan Zhang, Ying C. Ou   +5 more
wiley   +1 more source

Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation [PDF]

, 2001
Calatzis, A., Schiffl, Helmut, Schramm, W., Spannagl, M., Toepfer, Marcel   +4 more
core   +1 more source

Hemorrhagic Events Associated With Direct Oral Anticoagulants: Frequency and Management. [PDF]

Cureus
Ztati M, Zaanouny O, Nasim A, El Hattaoui M.   +3 more
europepmc   +1 more source

New Anticoagulants [PDF]

Circulation, 2010
John W, Eikelboom, Jeffrey I, Weitz
openaire   +2 more sources

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review

Chest, 2017
B. Samuelson, A. Cuker, D. Siegal, M. Crowther, D. Garcia   +4 more
semanticscholar   +1 more source

Comparative Bioequivalence and Safety Evaluation of Ibuprofen/Phenylephrine Hydrochloride Fixed‐Dose Combination Tablets in Healthy Chinese Volunteers

Clinical Pharmacology in Drug Development, EarlyView.
Abstract This single‐center, randomized, open‐label bioequivalence program compared two fixed‐dose combination (FDC) tablets containing ibuprofen (200 mg) and phenylephrine hydrochloride (10 mg) from different manufacturers in healthy Chinese adults under fasting and fed conditions. A three‐period, partially replicated crossover design was used for the
Menghan Ye, Rui Zhang, Jing Wan, Jinping Zhou, Pengpeng Guo, Dianwen Yu, Peixia Li, Yani Liu, Shaojun Shi   +8 more
wiley   +1 more source